首页> 外国专利> Derivatives of piperidine with beta2 adrenergic receptor agonist activity and Muscarinic receptor antagonist, Pharmaceutical compositions containing Same, use thereof for the manufacture of medicaments for the treatment of pulmonary diseases, Methods for preparing these der

Derivatives of piperidine with beta2 adrenergic receptor agonist activity and Muscarinic receptor antagonist, Pharmaceutical compositions containing Same, use thereof for the manufacture of medicaments for the treatment of pulmonary diseases, Methods for preparing these der

机译:具有β2肾上腺素能受体激动剂活性的哌啶衍生物和毒蕈碱受体拮抗剂,含有该衍生物的药物组合物,其在制备用于治疗肺部疾病的药物中的用途,其制备方法

摘要

Claim 1: a compound of formula (1): wherein R1 is Methyl or Ethyl, R2 is Methyl or Ethyl, or a Salt or solvate or stereoisomer thereof acceptable for pharmaceutical use.Claim 21: an intermediate for preparing a compound of any of claims 1 to 4, wherein the Agent is a compound of formula (3): where Y1 is selected from Cho, - CN, - CH2OH (or3a) or3b, - ch, - C (o) Oh, - C (o) or3c, Bromine and iodine, where R3A and r3b is selec Each year, including Rent C1 - 6Or R3A and R2H are United to form a alquileno C2 - 6, R3C is selected from alkyl C1 - 6; r1 is Methyl or Ethyl, R2 is Methyl or Ethyl, or a Salt or stereoisomer of the same.Pharmaceutical compositions and combinations comprising such Compounds, processes and Intermediates for preparing such Compounds, and Methods of using Said Compound, for example, to treat pulmonary Disorders such as chronic obstructive pulmonary disease, and Asthma.
机译:1。一种式(1)的化合物:其中R 1是甲基或乙基,R 2是甲基或乙基,或其药学上可接受的盐或溶剂化物或立体异构体。权利要求21:一种用于制备权利要求中任一项的化合物的中间体。 1-4,其中所述试剂是式(3)的化合物:其中Y 1选自Cho​​,-CN,-CH 2 OH(or3a)或3b,-ch,-C(o)Oh,-C(o)或3c,每年含R3A和r3b的溴和碘,包括C1-6租金或R3A和R2H联合形成alquileno C2-6,R3C选自烷基C1-6; r1是甲基或乙基,R2是甲基或乙基,或它们的盐或立体异构体。包含此类化合物的药物组合物和组合,制备此类化合物的方法和中间体以及使用所述化合物的方法,例如,用于治疗肺慢性阻塞性肺疾病和哮喘等疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号